Identification |
Name: | 2(1H)-Quinolinone, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro- |
Synonyms: | Aripiprazole [USAN];Aripiprazole (JAN/USAN);2(1H)-Quinolinone,7-[4-[4-(2,3-dichlorophenyl)- 1-piperazinyl]butoxy]-3,4-dihydro-;7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone;Abilitat;7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone;OPC-14597;Abilify (TN);Abilify;7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one;OPC 31;2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-;Opc 14597;Arpiprazole;Alipiprazole;Aripiprzole;Aripipazole;7-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy)-3,4-dihydroquinolin-2(1H)-one; |
CAS: | 129722-12-9 |
EINECS: | 448.39 |
Molecular Formula: | C23H27Cl2N3O2 |
Molecular Weight: | 448.39 |
InChI: | InChI=1/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29) |
Molecular Structure: |
|
Properties |
Density: | 1.263 g/cm3 |
Refractive index: | 1.593 |
Solubility: | Insoluble |
Appearance: | colourless flake crystalline solid |
Specification: |
?Aripiprazole , its cas register number is 129722-12-9. It also can be called Aripiprazole [USAN] ; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone ; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril ; 7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone ; Abilify ; Abilify Discmelt ; Abilitat ;? Discmelt ; 2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro- .It is a?colourless flake crystalline solid.
|
Storage Temperature: | Store in original container in a cool dark place. |
Color: | Colorless, flake crystals from ethanol |
Usage: | A deuterated version of Aripiprazole, a selective dopamine D2-receptor antagonist with dopamine autoreceptor agonist activity. Please note that users have reported separation of this compound and aripiprazole under normal-phase and reverse-phase |
Safety Data |
|
|